ArticleFrontiers in pharmacology2021

Cost-Effectiveness of Frontline Treatment for Advanced Renal Cell Carcinoma in the Era of Immunotherapies.

SiNi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.